alexa Perspective Of Using Inhibitors Of Proteolysis For Antiviral Treatment | 71575
ISSN: 1948-5948

Journal of Microbial & Biochemical Technology
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

CO-ORGANIZED EVENT: International Conference on Chronic Diseases & 6th International Conference on Microbial Physiology and Genomics

Valentina Divocha
State Enterprise “Ukrainian Research Institute for Medicine of Transport”, Ukraine
Posters & Accepted Abstracts: J Microb Biochem Technol
DOI: 10.4172/1948-5948-C1-029
Abstract
We presented the new theory of flu pathogenesis with participation of proteinases-inhibitory system is offered. Cleaning and concentration of flu virus with centrifugation does not exempt virus from proteins with proteinases activity. Additional cleaning of flu virus in saccharobise’s ladder-shaped gradient showed that the main quantity of flu virus and the greater part of proteolytic activity has been localized around 38-43% saccharobise’s concentration. Primarily associated flu virus proteinase in sacchorobise’s gradient was divided into four isoforms, and proteinase from normal horionallantoisny membranes – into 3 isoforms. The latter were 345 times lower than virus inductive forms. During experimental animal’s infection by flu virus, there was violation of fermentative and inhibitory balance, especially during the first hours after infection. Virus-inductive cellular inhibitor plays an important role in proteinase blocking during first hours after infection. After its exhaustion, the leading role in the development of infection is assumed by trypsin-like proteinases which started to split hemagglutinin and in this connection, there was the growth of an infectious titer. From the lungs of healthy mice, six isoforms of trypsin-like proteinase have been discharged. To them anti-protease immune sera were obtained and the treatment of animals with their use was carried out. 60% of the mice survived only at the effect of anti-serum to the III isoform. Inhibitor of trypsin-like proteinases emitted from the lungs of healthy mice, protected the experimental animals from death for 80% and is a perspective antiinfluenza drug. It has been established that the greatest number of trypsin-like proteinase and its inhibitor contained in the fractions of waste of the I and II stages of industrial manufacturing of gamma-globulin and albumin from donor blood which are utilized.
Biography

Valentina Divocha graduated from I I Mechnikov Odessa State University, Faculty of Biology (Department of Virology) in 1967. She continued her Postgraduate study at Odessa Institute of Virology and Epidemiology specializing in Virology (1973). In 1974, she was awarded her Candidate Degree with the thesis "Interaction of coxsackie B viruses with sensitive cell cultures and their antigenic relationships." In 2009, she was awarded her Doctoral Degree with the thesis entitled, "Biological basis antiproteinase therapy of influenza". She has guided a Doctoral and two Master's theses. She has 35 years of experience. She has more than 190 scientific publications, 3 monographs, textbook "Virology" (2012), 10 patents, and 3 innovations. She is currently working as the Head of the Laboratory of Experimental and Clinical Pathology for Ukrainian Research Institute of Transport Medicine, and is the Supervisor of the nine research programs in Virology and Biochemistry.

image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7